These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25882057)

  • 1. Kawasaki disease: an evolving paradigm.
    Greco A; De Virgilio A; Rizzo MI; Tombolini M; Gallo A; Fusconi M; Ruoppolo G; Pagliuca G; Martellucci S; de Vincentiis M
    Autoimmun Rev; 2015 Aug; 14(8):703-9. PubMed ID: 25882057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kawasaki disease: a comprehensive review of treatment options.
    Patel RM; Shulman ST
    J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. School-aged children with Kawasaki disease: high incidence of cervical lymphadenopathy and coronary artery involvement.
    Fan PC; Chiu CH; Yen MH; Huang YC; Li CC; Lin TY
    J Paediatr Child Health; 2003; 39(1):55-7. PubMed ID: 12542814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kawasaki disease complicating bilateral facial nerve palsy and giant coronary artery aneurysms: A case report.
    Yu X; Liu X; Wang Y; Lu N; Wang M; Sun L
    Medicine (Baltimore); 2019 Feb; 98(7):e14395. PubMed ID: 30762741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA;
    Pediatrics; 2004 Dec; 114(6):1708-33. PubMed ID: 15574639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA; ; ; ;
    Circulation; 2004 Oct; 110(17):2747-71. PubMed ID: 15505111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of kawasaki disease.
    Saguil A; Fargo M; Grogan S
    Am Fam Physician; 2015 Mar; 91(6):365-71. PubMed ID: 25822554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting Kawasaki disease: a state-of-the-art review.
    Dietz SM; van Stijn D; Burgner D; Levin M; Kuipers IM; Hutten BA; Kuijpers TW
    Eur J Pediatr; 2017 Aug; 176(8):995-1009. PubMed ID: 28656474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
    PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC; Corsello G; Prinzi E; Cimaz R
    Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
    Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
    Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kawasaki disease: what you need to know].
    Bajolle F; Laux D
    Arch Pediatr; 2012 Nov; 19(11):1264-8. PubMed ID: 22921712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC
    Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kawasaki disease.
    Kim DS
    Yonsei Med J; 2006 Dec; 47(6):759-72. PubMed ID: 17191303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoglobulin therapy].
    Ogata S; Ishii M
    Nihon Rinsho; 2014 Sep; 72(9):1617-22. PubMed ID: 25518412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kawasaki disease: Medical therapies.
    Newburger JW
    Congenit Heart Dis; 2017 Sep; 12(5):641-643. PubMed ID: 28580631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab as a novel therapy for refractory Kawasaki disease.
    Weiss JE; Eberhard BA; Chowdhury D; Gottlieb BS
    J Rheumatol; 2004 Apr; 31(4):808-10. PubMed ID: 15088313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand.
    Durongpisitkul K; Sangtawesin C; Khongphatthanayopthin A; Panamonta M; Sopontammarak S; Sittiwangkul R; Pongpanich B
    Asian Pac J Allergy Immunol; 2006 Mar; 24(1):27-32. PubMed ID: 16913186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incomplete Kawaski disease: are we missing it?
    Billoo AG; Lone SW; Siddiqui S; Atiq H
    J Pak Med Assoc; 2009 Jan; 59(1):42-3. PubMed ID: 19213377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.